Small cell lung cancer(SCLC)accounts for approximately 20% of lung carcinomas. Nearly 30% of patients with lung cancer are diagnosed over the age of 70 years and about 10% over 80 years. Chemotherapy is the cornerstone of treatment for SCLC. However,elderly patients tolerate chemotherapy poorly as compared to their younger counterparts because of age-related progressive reduction in organ functions and the presence of comorbidities. Therefore,the best approach towards the development of active and well-tole...
【基金】
辽宁省省直医院改革重点临床科室诊疗能力建设项目(LNCC-D07-2015)
【更新日期】
2017-09-12
【分类号】
R734.2
【正文快照】
小细胞肺癌(small cell lung cancer,SCLC)约占肺癌的15%~20%[1]。SCLC在美国国立综合癌症网络(national comprehensive cancer network,NCCN)指南和ESMO指南都采用TNM分期,即按照肿瘤大小侵犯范围、淋巴结转移程度及远隔转移进行分期。而临床最常用的分期系统为美国退伍军人医
| 
推荐 
点击下列相关研究机构和相关文献作者，可以直接查到这些机构和作者被《中国知识资源总库》收录的其它文献，使您全面了解该机构和该作者的研究动态和历史。
